World Leaders in Proteomics and Genomics to Convene at the 2nd International Top-Down Proteomics Symposium
September 20, 2023 11:11 ET
|
Consortium for Top-Down Proteomics
Building the bridge from genotype to phenotype, the Symposium will feature scientific leaders creating cutting edge technologies and approaches that are ushering in the era of proteoform systems...
Pacific Biosciences Launches New HiFi Sequencing Workflow to Further Improve HiFi’s Industry Leading Accuracy
April 26, 2021 08:00 ET
|
Pacific Biosciences of California, Inc.
HiFi Sequencing and Software v10.1 Release on the Sequel II and IIe Systems Increases Scalability, Improves Usability, and Unlocks Additional Sample Types to Extend the Value of HiFi Reads MENLO...
Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy Diagnostics
October 22, 2020 08:00 ET
|
Pacific Biosciences of California, Inc.
SAN FRANCISCO and MENLO PARK, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a...
Pacific Biosciences Launches the Sequel IIe System to Accelerate Adoption of Highly Accurate HiFi Sequencing
October 05, 2020 08:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes,...
Pacific Biosciences Announces Issuance of U.S. Patent for Concatemer Sequencing
March 13, 2018 07:30 ET
|
Pacific Biosciences, Inc.
MENLO PARK, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that the U.S....
Pacific Biosciences Enhances Performance and Affordability of Key Applications on the Sequel System
March 07, 2018 07:30 ET
|
Pacific Biosciences, Inc.
MENLO PARK, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced a new version of...
Novogene and Pacific Biosciences to Jointly Develop and Co-Market Novel Applications Based on Sequel Platform
July 18, 2017 08:00 ET
|
Pacific Biosciences, Inc.
SAN DIEGO and MENLO PARK, Calif., July 18, 2017 (GLOBE NEWSWIRE) -- Novogene, a leading global provider of genomic services and solutions, and Pacific Biosciences of California, Inc. (NASDAQ:PACB),...